Author:
Varrassi Giustino,Marinangeli F.,Donatelli F.,Beltrutti D.
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Hassenbusch SJ, Paice JA, Patt RB, Bedder MD, et al.: Clinical realities and economic considerations: economics of intrathecal therapy. J Pain Symptom Manage 1997, 14(3 suppl):S36-S48.
2. Manfredi PL, Chandler SW, Patt R, Payne R: High-dose epidural infusion of opioids for cancer pain: cost issues. J Pain Symptom Manage 1997, 13:118–121.
3. Jeal W, Benfield P: Transdermal fentanyl. Drugs 1997, 53:109–138. This is a complete review about transdermal fentanyl. Pharmacodynamic and pharmacokinetic properties are well described. Possible clinical uses are considered and the review takes into account pharmacoeconomic considerations.
4. Roback B, Thirlwell M, Cowans M, et al.: Potential cost savings with fentanyl patches in comparison to oral or parenteral opioid: a pilot study. American Pain Society 14th Annual General Meeting, Sept 17-21, 1995; Montreal.
5. Stommel M, Given CW, Given BA: The cost of cancer home care to families. Cancer 1993, 71:1867–1874.